485 ROUTE 1 SOUTH, ISELIN, NJ
Market cap: $20.9M (2/10/2026)
Price: $0.47
Submits Type A Meeting Request to FDA Following Complete Response Letter
Annual Report to Security Holders
Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
Reports Financial Results for Fiscal Year 2025
Re-Submits Biologics License Application for ONS-5010
Provides Update on Type A Meeting with FDA
Changes in Board, Management or Compensation
FY 2025
Q3
Q1
Amended Annual Report
FY 2024
Q2
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership